Sound Bites from the Field     THERE ARE NUMEROUS FACTORS AFFECTING CHANGE IN THE MARKETING OF SPECIALTY PRODUCTS TODAY.  ...
Upcoming SlideShare
Loading in …5
×

The Navicor Group, When Smaller is Better Pharma Voice article

427 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
427
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

The Navicor Group, When Smaller is Better Pharma Voice article

  1. 1. Sound Bites from the Field THERE ARE NUMEROUS FACTORS AFFECTING CHANGE IN THE MARKETING OF SPECIALTY PRODUCTS TODAY. WE ASKED EXPERTS IN THE FIELD TO COMMENT ON WHAT THEY BELIEVE TO BE THE MOST SIGNIFICANT. JAY CARTER is Senior VP at AbelsonTaylor Inc.,Chicago,a GARNETT DEZEMBER is President of The Navicor Group, “ The very definition of a specialty product is an issue medical and pharmaceutical inVentiv Communications, today.In the past,these products advertising agency.For Westerville,Ohio,a full-service were used by select physicians in more information,visit advertising agency specializing controlled settings for niche abelsontaylor.com. in oncology and immunology. diseases,and a linear approach For more information,visit navicorgroup.com. was used to market to these physicians.Today, “ Economics favor niche products that meet these conversations are fragmented and inclusive an unmet need.Advocacy groups for the disease state are focused upon an area that is “ Assuming that the definition of ‘specialty products’in the broadest and most traditional of diverse and vast audiences.Patients,caregivers, physicians,regulators,and payers are sharing probably under-resourced,the opinion leaders terms is ‘products targeted to nonprimary care information more readily and making decisions in a are predisposed to embrace a product that healthcare providers,’then a major trend is toward community context,in part thanks to technology. offers an improvement,and practicing treatment diagnostics.That is,using diagnostic Therefore,the uptake and potential for specialty physicians who specialize in treating a niche testing to predict which treatments will provide products are enhanced,and we hear of ‘specialty disease just want something new that works. patients the greatest benefit.This heightened blockbusters’as the new model of success. Couple these factors with high demand from a precision will enable healthcare providers to treat Those who can leverage their brand’s ‘common small group of prescribers,and brand teams with greater outcome assurance,increase quality of diversity’across audiences and media will enjoy can service the group with a smaller and less life for patients,and reduce overall healthcare costs. strategically sound growth no matter how specialty expensive salesforce.This leads to high returns, at least for a time. As the role of treatment diagnostics increases, marketing becomes more interesting because ” is defined. Unfortunately,as Thomas Wilmott of patient selection becomes more critical.Traditional STEVEN MICHAELSON is International Data Corp.puts it,‘defending a patient profiles are no longer as valuable as they Founder and CEO of Wishbone niche is like being in the Alamo.’Once the used to be.The appropriate diagnostic tool will ITP,New York,an independent, market is created and there is proof of concept require coordinated marketing alongside its full service healthcare advertis- for a class of agents that successfully meets the partner therapy to create a combination value ing agency.For more informa- needs of the market,competition rushes in. proposition.Also,additional key audiences will tion,visit wishbone-itp.com. The best marketing strategy to deal with likely need to be targeted.For instance,with cancer, competition was best articulated 2,500 years ago, by Sun-Tzu:‘Whoever is first in the field where oncologists were once the primary target audience,surgeons and pathologists may take a “ From the specialty pharma perspective,the primary issue is salesforce effectiveness.Specialty and awaits the coming of the enemy will be fresh for the fight; whoever is second in the more critical role in drug treatment decisions. ” companies usually have good products and appropriate resourcing relative to the size of their field and has to hasten to battle will arrive GEORGE GLATCZ JR. is President of Vox Medica, audience.Unfortunately,it is difficult for them to exhausted.’ Philadelphia, a communications company attract and retain top sales talent and as result they New specialty players have the advantage focused on building brand recognition and are unable to gain access and make appropriate of being more nimble than many of their big visibility, customizing meaningful education and impact against key physician targets.On the pharma competitors,and their principal knowledge solutions, and delivering market specialty product front,the primary trend occurring advantage is the all-important first mover access to healthcare clients worldwide. For more in the marketing of specialty products is the advantage. ” information, visit voxmedica.com. development of patient communities and the18 September 2008 PharmaVOICE PDF created for: PharmaVOICE Editorial (edit@pharmavoice.com) 9/11/2008

×